0 (0%) | 10-15 12:19 | |||||||||||||
|
|
Short term | ![]() ![]() ![]() |
|||
Mid term | ![]() |
|||
Targets | 6-month : | 8.86 | 1-year : | 10.35 |
Resists | First : | 7.59 | Second : | 8.86 |
Pivot price | 7.12 ![]() |
|||
Supports | First : | 6.79 | Second : | 6.3 |
MAs | MA(5) : | 7.05 ![]() |
MA(20) : | 7.02 ![]() |
MA(100) : | 5.43 ![]() |
MA(250) : | 4.01 ![]() |
|
MACD | MACD : | 0.2 ![]() |
Signal : | 0.3 ![]() |
%K %D | K(14,3) : | 56.2 ![]() |
D(3) : | 44.9 ![]() |
RSI | RSI(14): 65.8 ![]() |
|||
52-week | High : | 7.59 | Low : | 2.43 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ NGD ] has closed below upper band by 22.1%. Bollinger Bands are 9.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
If tomorrow: | Open lower | Open higher |
High: | 7.26 - 7.3 | 7.3 - 7.33 |
Low: | 6.9 - 6.94 | 6.94 - 6.97 |
Close: | 7.05 - 7.12 | 7.12 - 7.18 |
Wed, 15 Oct 2025
Next Gen Diagnostics Expands U.S. Operations With New Lab in Kendall Square - The Northwest Florida Daily News
Wed, 15 Oct 2025
Next Gen Diagnostics Expands U.S. Operations With New Lab in Kendall Square - Erie Times-News
Mon, 13 Oct 2025
Is New Gold (TSX:NGD) Undervalued After Its Impressive Year-to-Date Rally? - Yahoo Finance
Mon, 13 Oct 2025
New Gold (TSX:NGD) Valuation: Is There More Upside After a 153% Year-to-Date Surge? - simplywall.st
Fri, 10 Oct 2025
CIBC Maintains New Gold (NGD) Outperformer Recommendation - Nasdaq
Fri, 10 Oct 2025
New Analyst Forecast: $NGD Given $9.5 Price Target - Quiver Quantitative
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
Exchange:
|
|
Sector:
|
|
Industry:
|
|
Shares Out | 792 (M) |
Shares Float | 762 (M) |
Held by Insiders | 3.7 (%) |
Held by Institutions | 65.5 (%) |
Shares Short | 14,490 (K) |
Shares Short P.Month | 15,860 (K) |
EPS | 0.2 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 1.38 |
Profit Margin | 14 % |
Operating Margin | 34.3 % |
Return on Assets (ttm) | 7.7 % |
Return on Equity (ttm) | 14.1 % |
Qtrly Rev. Growth | 41.2 % |
Gross Profit (p.s.) | 0.75 |
Sales Per Share | 1.3 |
EBITDA (p.s.) | 0.65 |
Qtrly Earnings Growth | 23.7 % |
Operating Cash Flow | 508 (M) |
Levered Free Cash Flow | -59 (M) |
PE Ratio | 36.75 |
PEG Ratio | 0 |
Price to Book value | 5.28 |
Price to Sales | 5.64 |
Price to Cash Flow | 11.45 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |